$EXTR

Edward Meyercord, Extreme Networks CEO, sells $1.09m in shares

Extreme Networks (EXTR) CEO Edward Meyercord sold 50,000 shares for $1.09M. The stock fell 10% last week. InvestingPro lists EXTR as undervalued. Q4 earnings beat estimates with $0.32 EPS and $338.6M revenue. UBS maintains a Neutral rating with a $28 target. EXTR's AI platform drove half of subscription bookings.

Original reporting
Published Oct 18, 2026, 12:17 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 18, 2026, 5:54 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$EXTR
Bearish
medium confidence
Mentioned
$EXTR
Relevance
5/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$EXTRBearishLow
01

Why it matters

The insider sale adds a negative catalyst to an already pressured stock, potentially prompting short‑term declines.

02

Market read

New insider sale amid recent earnings beat creates a mixed signal for traders.

03

What to watch

Recent earnings beat and strong AI platform bookings may offset sell‑off pressure.

Relevance 5/10Novelty 4/10Timing: today

Background

Extreme Networks recently reported Q4 earnings that beat expectations, but the stock fell pre‑market on growth outlook concerns.

Company-level read

Ticker impact

$EXTRBearishMedium confidence
Context

CEO Edward Meyercord sold 50,000 shares for $1.09M via a 10b5-1 plan, a new insider sale disclosed today.

Expected impact

likely pressure as the market prices in the insider sell

Evidence & confidence

Insider sales often prompt short-term sell‑offs, especially after a recent price decline.

Market effects

Minimal; the sale does not materially affect the broader networking equipment sector.

Limited to U.S. investors tracking Extreme Networks.

Low; no global macro or sector ripple expected.

Counterpoint

The sale could be routine under a pre‑arranged plan and not reflect negative outlook.

Key entities

  • Edward Meyercord

    President and CEO of Extreme Networks

Related articles

$EXTRHighAI 9/10

Extreme Networks (EXTR) Q4 2026 Earnings Call Transcript

Extreme Networks (EXTR) reported Q4 FY2026 revenue of $338.6M, up 10.3% year over year, and non-GAAP EPS of $0.32. Full-year revenue rose to $1.28B and non-GAAP EPS to $1.06. Management guided FY2027 revenue of $1.38B to $1.4B and non-GAAP EPS of $1.28 to $1.33.

$EXTRMedAI 8/10

‘We’re Taking Share’: Extreme Networks CEO Sees MSPs, AI Driving Growth

Extreme Networks CEO Ed Meyercord said the company is moving up-market and expanding its MSP channel, with about 85% of revenue via indirect channels. It reported fiscal 2026 results before market open, with quarterly subscription bookings rising from about $3M to about $50M, and said it guided to lower next-year growth, which contributed to a 19% stock drop to $25.20.

$EXTRMed

Extreme Networks, Inc. Q4 2026 Earnings Call Summary

Extreme Networks reported 13% fiscal 2026 revenue growth and said Platform ONE drove nearly half of Q4 subscription bookings. It expects fiscal 2027 revenue of $1.38 billion to $1.4 billion and earnings growth of 20% plus, with half of the installed base migrating to Platform ONE by end of fiscal 2027. The company also discussed supply, pricing, and SaaS ARR reacceleration.

$EXTRHighAI 9/10

Extreme Networks Q4 Earnings Call Highlights

Extreme Networks (NASDAQ:EXTR) reported Q4 operating margin of 15.7% and EBITDA of $59 million (17.5% margin), with $65 million in cash flow and $47 million net cash. Full-year non-GAAP operating margin rose 60 bps to 14.8%, EBITDA increased 20% to $210 million, and it repurchased $25 million of shares at $16.66. Q1 FY2027 revenue forecast is $334M-$339M; full-year revenue $1.38B-$1.40B.

$EXTRHigh

Extreme Networks Reports Fourth Quarter and Fiscal Year 2026 Financial Results

EXTREME NETWORKS INC (EXTR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 For more information, contact: Investor Relations Media Contact Stan Kovler Amy Aylward 919/595-4196 603/952-5138 Investor_relations@extremenetworks.com pr@extremenetworks.com Extreme Networks Reports Fourth Quarter and Fiscal Year 2026 Financial Results FY26 Revenue

$VRTXMed

Vertex Highlights Kidney Pipeline as Povetacicept Cuts Proteinuria 52% in Phase III

Vertex Pharmaceuticals reported positive Phase III results for povetacicept, showing a 52% reduction in proteinuria in kidney disease patients. The drug's safety profile was similar to placebo. Vertex also discussed inaxaplin's potential in treating APOL1-mediated kidney disease, with Phase III AMPLITUDE trial results expected early next year. The company is engaging with payers for povetacicept's commercial coverage.